HPV-Impfung zur Prävention von Genitalwarzen und Krebsvorstufen – Evidenzlage und Bewertung

Translated title of the contribution: HPV vaccination and the prevention of genital warts and precancerous lesions—current evidence and evaluation

Vanesa Osmani, Stefanie J. Klug

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Abstract

Human papillomaviruses (HPVs) can cause both benign and malignant tumors. To date, more than 200 HPV types have been discovered, of which 12 are currently classified as high risk for cervical cancer. HPV types that affect the anogenital tract are sexually transmitted. Since 2006, prophylactic HPV vaccines have been available and should be administered before first sexual contact. HPVs infect epithelial cells and are worldwide the most common sexually transmitted viruses. Apart from cervical cancer, HPVs cause other anogenital cancers such as vulvar, vaginal, and anal cancer but also oropharyngeal cancer (or head and neck cancers). HPV types 16 and 18 are also found at these sites. HPV types 6 and 11 are associated with genital warts; other HPV types can cause harmless skin warts. HPV vaccines are safe and highly effective, if they are administered before exposure to HPV. Systematic reviews and meta-analyses have shown that HPV vaccination effectively prevents HPV infection, but also precancerous lesions of the anogenital tract and genital warts. Recent vaccination data also demonstrate reductions in cervical cancer incidence. The uptake rates of HPV vaccination vary worldwide by program and acceptance. In comparison to other European countries, Germany has a low uptake rate. The Standing Committee on Vaccination (STIKO) recommends HPV vaccinations for all girls and boys ages 9 to 14 years in Germany. In 2018, only half of all 18-year-old girls in Germany were completely immunized against HPV. Organized vaccination programs, whether population-based or school-based, are necessary in order to increase vaccination uptake rates.

Translated title of the contributionHPV vaccination and the prevention of genital warts and precancerous lesions—current evidence and evaluation
Original languageGerman
Pages (from-to)590-599
Number of pages10
JournalBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Volume64
Issue number5
DOIs
StatePublished - May 2021

Fingerprint

Dive into the research topics of 'HPV vaccination and the prevention of genital warts and precancerous lesions—current evidence and evaluation'. Together they form a unique fingerprint.

Cite this